2m 2m 2m 2m 2m 2m 2m
RAPPORT THERA (RAPP)
NASDAQ
$27.35+$2.29 (+9.14%)
Price as of Oct 22, 2026 7:44 PM EDT- $1.2BMarket Cap
- 0.64%1-Year Change
- BiotechnologyIndustry
RAPPORT THERA (RAPP)
$27.35+$2.29 (+9.14%)
RAPP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $25.06 | ||
Change | -$4.31 (-14.67%) | ||
Open | $29.91 | ||
High | $29.91 | ||
Low | $24.69 | ||
Previous Close | $29.37 | ||
Volume | 2,161,677 | ||
30-Day Average Volume | 844,696 | ||
1-Week Change | -11.54% | ||
1-Month Change | -36.81% | ||
1-Year Change | 0.64% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 48.0M | ||
Total Assets | $459.0M | ||
Market Cap | $1.2B | ||
Enterprise Value | $1.1B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$56.6M | ||
Free Cash Flow | -$41.5M | ||
EBIT | -$56.6M | ||
EBITDA | -$56.4M | ||
Net Working Capital | $418.4M | ||
EPS | -$1.19 | ||
Enterprise Value/EBITDA | -20 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -21 | ||
PEG | 0 | ||
Price/Free Cash Flow | -29 | ||
Price/Operating Cash Flow | -29 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue